Skip to main content

Table 4 RFS and recurrence rates in the high-risk and low-risk groups

From: Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram

 

Training Dataset

N = 129

Validation Dataset N = 55

High-Risk Group

Low-Risk Group

P-value

High-Risk Group

Low-Risk Group

P-value

No. of patients (%)

65 (50.4)

64 (49.6)

 

24 (43.6)

31 (56.4)

 

1-year RFS Median, (IQR)

4.5 (2.0–6.25)

7 (5–10)

0.004

4 (2–5)

8 (2–8)

0.2169

2-year RFS Median, (IQR)

5 (2.25–9)

11 (7–16)

< 0.001

6.5 (3–15)

10 (5.75–15.5)

0.3402

3-year RFS Median, (IQR)

6 (3.0–16.0)

13 (7.5–19)

0.024

9 (3.5–16.5)

17.5 (8.0–26)

0.044

No. of recurrences (%)

 At 1 year

44 (34.1)

16 (12.4)

 

13 (23.6)

9 (14.5)

 

 At 2 year

54 (41.9)

29 (22.5)

 

20 (36.4)

14 (20.0)

 

 At 3 year

63 (48.8)

39 (30.2)

 

23 (41.8)

22 (40.0)

Â